Demonstrated in vivo effect

Follow

Industry

CPC
C12N2760/12271

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12NMICRO-ORGANISMS OR ENZYMES COMPOSITIONS THEREOF PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS MUTATION OR GENETIC ENGINEERING CULTURE MEDIA C12N2760/00ssRNA Viruses negative-sense

Current Industry

C12N2760/12271Demonstrated in vivo effect

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Rift valley fever virus replicon particles and use thereof
- Patent number 9,687,542
- Issue date Jun 27, 2017
- The Government of the United States of America as represented by the Secretar...
- Kimberly A. Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ATTENUATED VARIANT OF THE RIFT VALLEY FEVER VIRUS, COMPOSITION COMP...
- Publication number 20230212529
- Publication date Jul 6, 2023
- Alejandro BRUN TORRES
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
A NOVEL DNA VACCINE AGAINST CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (...
- Publication number 20210401965
- Publication date Dec 30, 2021
- The Wistar Institute of Anatomy and Biology
- Kar Muthumani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...